NCT03895892

Brief Summary

20 healthy recreationally active men and woman aged 18-35 will participate in the study. There will be three treatments involved: Caffeinated ketone supplements, non-caffeinated ketone supplement and water-placebo. Participants will complete the protocol three times and the treatment order will be systematically rotated to avoid any order effect. The three main trials will be separated by at least 1 week. After providing the corresponding treatment, participants will be given 30 minutes and after, they will perform a standardized 10-minute warm-up, followed by the 20 km time trial and a 30-second all-out Wingate test.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 13, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 29, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

May 15, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

October 2, 2019

Status Verified

September 1, 2019

Enrollment Period

7 months

First QC Date

February 13, 2019

Last Update Submit

September 30, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • 20 km time trial

    participants will ride for 20 km on a stationary bike and time to complete distance will be measured.

    40 minutes

  • Wingate test

    participants will perform a ver short all-out effort on a stationary bike. peak power output and fatigue index will be measured.

    30 seconds

Secondary Outcomes (3)

  • Blood Ketone

    1 hour

  • Blood Lactate

    1 hour

  • Rates of perceived exertion (RPE)

    1 hour

Study Arms (3)

Water Placebo

PLACEBO COMPARATOR

Placebo flavored drink similar to treatments but with no energy will be ingested before completing a 20km Time trial and a 30 second all-out Wingate test

Behavioral: 20 km time trialBehavioral: Wingate testDietary Supplement: Water Placebo

Experimental 1

EXPERIMENTAL

Ketone salts supplement mixed in water will be ingested before completing a 20km Time trial and a 30 second all-out Wingate test

Behavioral: 20 km time trialBehavioral: Wingate testDietary Supplement: Ketone

Experimental 2

EXPERIMENTAL

Ketone salts/caffeine supplement mixed in water will be ingested before completing a 20km Time trial and a 30 second all-out Wingate test

Behavioral: 20 km time trialBehavioral: Wingate testDietary Supplement: Ketone/Caffeine

Interventions

20 km time trial cycling test will be conducted to measure the effect of different drinks on time

Experimental 1Experimental 2Water Placebo
Wingate testBEHAVIORAL

30 second all-out effort on a bike will be conducted to measure the effect of different drinks on peak power output

Experimental 1Experimental 2Water Placebo
Ketone/CaffeineDIETARY_SUPPLEMENT

Dietary supplement containing ketone salts and caffeine

Experimental 2
KetoneDIETARY_SUPPLEMENT

Dietary supplement containing only ketone salts

Experimental 1
Water PlaceboDIETARY_SUPPLEMENT

Dietary supplement containing only water

Water Placebo

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy male and female recreationally active individuals
  • aged 15-35 years
  • non regular caffeine users.

You may not qualify if:

  • Smoker
  • Taking part in other research
  • Sedentary
  • For women, if they are pregnant or become pregnant during the study
  • Injury limiting exercise ability.
  • Have symptoms or take medication for respiratory disease
  • Have symptoms or take medication for cardiovascular disease
  • Have symptoms or take mediation for neuromuscular disease
  • Use heart rate or blood pressure medications
  • Use any medications with side effects of dizziness, lack of motor control, or slowed reaction time

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Exercise Nutrition Laboratory (Western University)

London, Ontario, N6A 3K7, Canada

RECRUITING

MeSH Terms

Conditions

Ketosis

Interventions

KetonesCaffeine

Condition Hierarchy (Ancestors)

AcidosisAcid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Organic ChemicalsXanthinesAlkaloidsHeterocyclic CompoundsPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Officials

  • Peter Lemon, PhD

    Western University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Peter Lemon, PhD

CONTACT

Manuel D Quinones, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Participants and investigators will be blinded as an individual not involved in the project will assemble and distribute the treatment (drinks) according to a coding system that is kept confidential until the study is completed. Participants will complete the protocol three times and the treatment order will be systematically rotated to avoid any order effect. taste and texture of treatments will be matched and will be distribute in opaque bottles to keep participant blinded
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: This will be a double blind repeated measures cross over study. There will be three treatments involved: Caffeinated ketone supplements, non-caffeinated ketone supplement and water-placebo. Participants will complete the protocol three times and the treatment order will be systematically rotated to avoid any order effect. Design of the study is composed of two performance tests 30 minutes following supplementation. All participants will arrive in a fed state to the laboratory. the corresponding treatment will be provided and 30 minutes later, they will perform a 20 km time trial. 10 minutes after the time trial, participants will perform a 30 second all-out Wingate test.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 13, 2019

First Posted

March 29, 2019

Study Start

May 15, 2019

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

October 2, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations